AMIX

News

globenewswire.comAutonomix Announces Reverse Stock Splitglobenewswire.comJun 18

globenewswire.comAutonomix Medical Announces Release of New CEO Corner Segment Highlighting Global Scientific and Clinical Recognition of Platform Technologyglobenewswire.comJun 10

globenewswire.comAutonomix Medical Highlights Clinical Data Presented at Society of Surgical Oncology Annual Meeting in Virtual Investor "What This Means" Segment Featuring City of Hope Chief of Medicineglobenewswire.comJun 4

Trade AMIX

About Autonomix Medical, Inc. Common Stock

Autonomix Medical, Inc. is an emerging medical device company focused on developing advanced solutions for identifying and treating various disorders impacting the peripheral nervous system. At the core of its innovation is a sophisticated technology platform that incorporates a catheter-based, microchip-enabled sensing array, engineered to precisely detect and differentiate peripheral neural signals. This Texas-based firm, headquartered in The Woodlands, was established in 2014.

CEO: Bradley Hauser
IPO Date: Jan 29, 2024

Market Data

Open: $0.3909
High: $0.3909
Low: $0.3642
Volume: 280.2K
Avg Volume: 706.8K
52W High: $2.64
52W Low: $0.20

Valuation

Market Cap: $1.9M
Enterprise Value: $-5.1M
Dividend Yield: 0.00%

Financials

Free Cash Flow: $-12M
Revenue: $0
Net Income: $-17M
Cash: $7.0M
Debt: $0

Events

EarningsAug 12

EPS est. -0.305